(Denver, CO and Philadelphia, PA) - Anjan Chatterjee, MD, has been awarded the Norman Geschwind Prize in Behavioral Neurology today by the American Academy of Neurology at their 54th annual meeting. Chatterjee is an associate professor in the Department of Neurology of the University of Pennsylvania School of Medicine.

Chatterjee receives the award on the basis of his research directed at understanding the architecture and neural basis for human cognition. The major emphasis of Chatterjee's lab is on the study of the human experience of attention, perception, and language. Chatterjee and his associates study normal people using functional neuroimaging and patients with selective deficits following brain damage to investigate mechanisms underlying human cognition.

"How we are able to experience our physical surroundings is a fascinating question that is rooted in the fundamental mechanisms of what we call consciousness," said Francisco Gonzalez-Scarano, MD, chair of the Department of Neurology. "This award is in recognition of Dr. Chatterjee's approach to expanding the scientific basis of neurobiological research."

Founded in 1999, the Norman Geschwind Prize is awarded to an individual for outstanding research in the field of behavioral neurology. The award honors the late Dr. Norman Geschwind, the Harvard Medical School and Boston University School of Medicine researcher who was pivotal in establishing the field of behavioral neurology in the United States. The prize is endowed by Geschwind's family, friends, colleagues, Parke-Davis Company and the Society for Behavioral and Cognitive Neurology. Chatterjee's lab is based at Penn's Center for Cognitive Neuroscience, a multidisciplinary group of researchers whose shared goal is to understand the neural basis of human thought. The center, formed in 1999, encompasses a wide range of research topics from vision and attention to semantic memory and executive functions.

# # #

The University of Pennsylvania Health System is distinguished not only by its historical significance - first hospital (1751), first medical school (1765), first university teaching hospital (1874), first fully integrated academic health system (1993) - but by its position as a major player on the world stage of medicine in the 21st century. Committed to a three-part mission of education, research, and clinical excellence, UPHS excels in all three areas.





Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.